Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.66 USD | +5.18% | +8.68% | -2.34% |
07-10 | Raymond James Initiates Bausch + Lomb at Outperform Rating With $19 Price Target | MT |
07-08 | RBC Capital on Bausch + Lomb's Miebo, Xiidra, Prescription Numbers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.34% | 5.57B | |
-6.68% | 179B | |
-5.20% | 98.84B | |
-5.38% | 65.34B | |
+15.46% | 45.41B | |
-6.47% | 44.94B | |
+9.74% | 43.76B | |
+14.01% | 29.01B | |
+19.39% | 25.65B | |
-6.53% | 23.32B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Bausch + Lomb Brief: Board has begun a search for a new CEO; Papa will remain as CEO and as a member of the Board until his successor is appointed